RM Global Partners
Overview
RM Global Partners is a life sciences-focused investment banking and advisory firm that provides services for mergers and acquisitions, financing, and strategic transactions, while also making principal investments and managing venture capital funds.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Odyssey Therapeutics | Sep 2025 | Series D | Co-investor |
| Altay Therapeutics | Oct 2026 | Series A | Co-investor |
| Acesion Pharma | Sep 2023 | Series B | Co-investor |
| Cartography Biosciences | Oct 2025 | Series B | Co-investor |
| Ensho Therapeutics | Jan 2026 | Series A | Co-investor |
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is RM Global Partners based?
RM Global Partners is headquartered in New York City, New York, United States.
When was RM Global Partners founded?
RM Global Partners was founded in 1992.
How many portfolio companies does RM Global Partners have?
RM Global Partners has 7 portfolio companies in Caplight's dataset.
What are some companies in RM Global Partners's portfolio?
Portfolio companies visible on Caplight include Odyssey Therapeutics, Altay Therapeutics, Acesion Pharma, Cartography Biosciences, Ensho Therapeutics.
What was RM Global Partners's most recent investment shown here?
RM Global Partners's most recent investment in this portfolio sample was in Altay Therapeutics in 2026.
What sectors does RM Global Partners focus on?
RM Global Partners focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences.
What company stages does RM Global Partners focus on?
RM Global Partners typically invests at the Mid stage.